Login
$AUPH
$17.25 +$0.21 (1.23%) Close

Insider Transactions

What Aurinia Pharmaceuticals Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 11
Sells 2 2
Total trades 2 41

Shares traded

3 months 12 months
Acquired 0 2,791,049
Disposed 32,914 713,613
Net activity −32,914 +2,077,436

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Robertson Stephen P. Chief Legal Officer Sep 10 Sale for tax withholding · S −11,939 $15.95 −$190K 588,848
Robertson Stephen P. Chief Legal Officer Aug 21 Sale for tax withholding · S −20,975 $16.97 −$356K 600,787
Tang Kevin Chief Executive Officer Jun 02 Open-market buy · P +206,005 $15.28 +$3.15M 13,044,106
Tang Kevin Chief Executive Officer Jun 01 Open-market buy · P +99 $15.34 +$1.52K 12,838,101
Tang Kevin Chief Executive Officer Jun 01 Open-market buy · P +343,521 $15.28 +$5.25M 12,838,002
Tang Kevin Chief Executive Officer May 29 Open-market buy · P +262,682 $15.31 +$4.02M 12,494,481
Tang Kevin Chief Executive Officer May 29 Open-market buy · P +2,299 $15.35 +$35.3K 12,231,799
Hearne Michael S Chief Financial Officer May 18 Grant / award · A +116,144 — — 116,144
Robertson Stephen P. Chief Legal Officer May 18 Grant / award · A +115,541 — — 621,402
Cole Ryan Chief Operating Officer May 18 Grant / award · A +116,144 — — 116,144
Keenan Greg SVP, Chief Medical Officer Mar 06 Withheld — tax / exercise cost · F −8,069 $14.32 −$116K 154,449
Tang Kevin Director Mar 03 Open-market buy · P +184,208 $14.22 +$2.62M 12,229,500
Tang Kevin Director Mar 02 Open-market buy · P +115,792 $14.21 +$1.65M 12,045,292
Tang Kevin Director Mar 02 Open-market buy · P +83,561 $14.33 +$1.2M 11,929,500
Miller Joseph M Chief Financial Officer Mar 02 Withheld — tax / exercise cost · F −37,511 $14.21 −$533K 576,421
Greenleaf Peter Chief Executive Officer Mar 02 Withheld — tax / exercise cost · F −100,890 $14.21 −$1.43M 1,840,379
Robertson Stephen P. EVP, General Counsel Mar 02 Withheld — tax / exercise cost · F −36,525 $14.21 −$519K 505,861
Donley Matthew Maxwell Chief Operating Officer Mar 02 Withheld — tax / exercise cost · F −40,761 $14.21 −$579K 680,299
Tang Kevin Director Feb 27 Open-market buy · P +1,600 $14.38 +$23K 11,845,939
Tang Kevin Director Feb 27 Open-market buy · P +214,839 $14.12 +$3.03M 11,844,339

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support